The Social Democratic candidate for mayor of Copenhagen, Pernille Rosenkrantz-Theil, wants to change the law so that “it should not be allowed to rent out anything other than the home where you have ...
Danske Bank has once again posted a record-breaking profit, reporting a post-tax surplus of 23.6 billion DKK for 2024 in its financial report for the last year. This is the best financial result ever ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...
However, Novo Nordisk (NYSE: NVO), a pioneer in the field, remains one of the leaders. That likely won't change anytime soon, since the Denmark-based pharmaceutical giant has an excellent pipeline.
WHY: New York, N.Y., February 3, 2025. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of ...
SAN DIEGO, CA / ACCESS Newswire / January 31, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of all investors ...
Bagsværd, Denmark, 27 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback